Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
E Van Cutsem, M Dicato, N Arber, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
G Rosati, G Ambrosini, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2012
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
T Pressiani, C Boni, L Rimassa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008
C Verslype, E Van Cutsem, M Dicato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
F Bonnetain, C Borg, R R Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
British Journal of Cancer
|
October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
A Ruzzo, F Graziano, Fabio Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2008
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007
E Van Cutsem, M Dicato, K Haustermans, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
E Van Cutsem, M Dicato, N Arber, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma
G Rosati, G Ambrosini, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2012
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
T Pressiani, C Boni, L Rimassa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008
C Verslype, E Van Cutsem, M Dicato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
F Bonnetain, C Borg, R R Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
British Journal of Cancer
|
October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
A Ruzzo, F Graziano, Fabio Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2008
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007
E Van Cutsem, M Dicato, K Haustermans, et al.
Page
of 17